Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Almeida J et al. - In a trial to assess the quality of life (QOL) of pts with differentiated thyroid cancer (DTC) and its potential clinical predictors, it was found that although QOL after treatment can be considered good for most pts, those submitted to radioactive iodine therapy (RIT) at doses higher than 150 mCi are at risk for poor QOL and may need more intensive follow-up and treatment.

Methods

Results

Related Articles

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
Thyroid, 10/30/09    Relevance Score: 71%

Diffuse Sclerosing Variant Is a Major Subtype of Papillary Thyroid Carcinoma in the Young
Thyroid, 11/06/09    Relevance Score: 70%

Geographical correlation between incidence of benign disease and that of cancer of the thyroid among the population of the Rhone-Alpes region of France
European Journal of Endocrinology, 10/14/09    Relevance Score: 69%

Thyroid Cancer in Systemic Lupus Erythematosus: A Case-Control Study
Journal of Clinical Endocrinology and Metabolism, 11/12/09    Relevance Score: 68%

Thyroid cancer a risk after childhood cancer
Reuters, 10/28/09    Relevance Score: 68%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address